Etiology and treatment of chronic bacterial prostatitis the Croatian experience

Save this PDF as:
 WORD  PNG  TXT  JPG

Size: px
Start display at page:

Download "Etiology and treatment of chronic bacterial prostatitis the Croatian experience"

Transcription

1 Etiology and treatment of chronic bacterial prostatitis the Croatian experience Višnja Škerk University Hospital for Infectious Diseases "Dr. Fran Mihaljevic" Zagreb Croatia Milano, Malpensa, 14 Nov 2008

2 The aim of our study was to investigate the etiology and treatment of chronic bacterial prostatitis, especially the significance of Chlamydia trachomatis and Ureaplasma urealyticum in prostatitis syndrome and the possibilities for treatment.

3 This research is a part of several scientific research projects of the Ministry of Science, Education and Sports of the Republic of Croatia: Urogenital infections caused by C. trachomatis (no ) Etiology and treatment of chronic prostatitis (no ) Clinical significance of urogenital mycoplasma (no ) Diagnosis and treatment of patients with prostatitis syndrome (no )

4 The study was conducted at the Outpatient Department for Urogenital Infections, University Hospital for Infectious Diseases Dr Fran Mihaljevic Zagreb, Croatia, between March 1, 1999 and June 30, The Ethics Committee of the Hospital approved the study. An informed consent was signed by all the patients.

5 PATIENTS In the 9 year study, we examined a total of 3029 patients over 18 years of age with symptoms of chronic prostatitis and no evidence of structural or functional lower genitourinary tract abnormalities.

6 The inclusion criteria for chronic prostatitis was the duration of symptoms for at least 3 months. The patients complained of one or more of the following symptoms: urethral symptoms (voiding dysfunction, urinary urgency, frequency, nocturia, dysuria) prostatic symptoms (pain and discomfort in the low back and in the perineal, suprapubic, penile, scrotal, or groin areas) sexual symptoms (pain during or after ejaculation or erectile dysfunction)

7 METHODS The following data were obtained for each patient: - medical history - clinical status - digitorectal prostatic examination - urethral swab specimens - selective samples of urine and EPS (Meares and Stamey 4-glass localization technique) - the severity of chronic prostatitis symptoms scored by the Croatian translation of the NIH-CPSI questionnaire was performed in only a small number of patients

8 METHODS Urethral swab specimens were examined for the presence of Chlamydia trachomatis, Ureaplasma urealyticum and Mycoplasma hominis.

9 METHODS Quantitative segmented cultures and bacterial identification as well as the number of leukocytes were determined in three voided urine samples (first voided- VB 1, midstream - VB 2, and urine bladder sample collected immediatelly after prostatic massage - VB 3 ) and expressed prostatic secretion (EPS). (Standard microbiological methods, Clinical Microbiology Laboratory of the Hospital)

10 METHODS EPS or VB 3 were examined for the presence of Chlamydia trachomatis, Ureaplasma urealyticum, Mycoplasma hominis and Trichomonas vaginalis.

11 METHODS Urogenital mycoplasma Trichomonas vaginalis Chlamydia trachomatis semiquantitative culturing antimicrobial susceptibility test Mycoplasma duo and S.I.R. Mycoplasma test (Clinical Microbiology Laboratory of the Hospital) culturing on DIAMOND modified medium (Clinical Microbiology Laboratory of the Hospital) isolation on McCoy cells Lugol stain ( ) immunofluorescent typing with monoclonal antibodies ( onging); (Croatian Institute for Public Health, Zagreb, Croatia) DNA/RNA Digene hybridization method (Clinical Microbiology Laboratory of the Hospital)

12 The diagnostic criteria for chronic bacterial prostatitis were as follows: - presence of clinical symptoms, - presence of 10 WBC s /hpf in EPS or VB 3 - a bacterial count of 10 3 cfu/ml or more, - if only Gram-positive cocci are found in EPS, a bacterial count of 10 4 cfu/ml or more is required, - finding of ten or many times greater number of bacteria in EPS or VB 3, than VB 1 or VB 2.

13 The diagnostic criteria for chronic prostatitis caused by C. trachomatis were: -presence of clinical symptoms, -presence of 10 WBCs /hpf in EPS or VB 3 -presence of C. trachomatis in EPS or VB 3 -absence of C. trachomatis in urethral swabs -absence of other possible pathogens of chronic prostatitis in urethral swabs, EPS or VB 3.

14 The diagnostic criteria for chronic prostatitis caused by U.urealyticum or M.hominis were: -presence of clinical symptoms, -presence of 10 WBCs /hpf in EPS or VB 3, -presence of U. urealyticum or M. hominis in EPS or VB 3, -absence of U. urealyticum or M. hominis in urethral swabs, -absence of other possible pathogens of chronic prostatitis in urethral swabs, EPS or VB 3

15 The diagnostic criteria for nonbacterial prostatitis or inflammatory chronic pelvic pain syndrom were: - presence of clinical symptoms, - presence of 10 WBCs /hpf in EPS or VB 3, - absence of possible bacterial pathogens of chronic prostatitis in EPS or VB 3, - presence of Trichomonas vaginalis in EPS or VB 3

16 The diagnostic criteria for non-inflammatory chronic pelvic pain syndrome were: - presence of clinical symptoms, - no white cells in EPS or VB 3 - absence of possible pathogens of chronic prostatitis in EPS or VB 3

17 RESULTS The etiology of chronic prostatitis syndrome in patients treated at the University Hospital for Infectious Diseases Dr Fran Mihaljevic from 1999 to 2008 Microorganism confirmed Patients in EPS or VB 3 > 10 WBCs/hpf in EPS < 10 WBCs/hpf in EPS Total no. no. (%) no. (%) no. (%) Chlamydia trachomatis 302 (15,46) 465 (43,26) 767 (25,16) Trichomonas vaginalis 211 (10,80) 101 (9,40) 312 (10,30) Ureaplasma urealyticum 158 (8,09) 63 (5,86) 221 (7,30) Escherichia coli 213 (10,90) 20 (1,86) 233 (7,69) Enterococcus 173 (8,85) 29 (2,70) 202 (6,67) Proteus mirabilis 73 (3,74) 7 (0,65) 80 (2,64) Klebsiella pneumoniae 34 (1,74) 4 (0,37) 38 (1,25) Streptococcus agalactiae 37 (1,89) 12 (1,12) 49 (1,62) Pseudomonas aeruginosa 5 (0,26) 2 (0,19) 7 (0,23) Mycoplasma hominis 15 (0,77) 12 (1,12) 27 (0,89) Staphylococcus aureus 2 (0,10) 2 (0,19) 4 (0,13) Mixed infection 74 (3,79) 31 (2,88) 105 (3,47) None 657 (33,62) 327 (30,42) 984 (32,49) Total

18 A high incidence of etiologically confirmed chronic prostatitis syndrome cases, especially high percentage of sexually transmitted pathogens, can be explained through: - selective population referred to our outpatient department due to a suspected urogenital or sexually transmitted infection - regular analysis in these patients for the presence of Chlamydia trachomatis, Ureaplasma urealyticum, Mycoplasma hominis and Trichomonas vaginalis with the most sophisticated microbiological methods

19 In the period from 1999 until 2006, a total of 389 patients with chronic bacterial prostatitis were treated with azithromycin: patients with chronic prostatitis caused by Chlamydia trachomatis - 82 patients with chronic prostatitis caused by Ureaplasma urealyticum

20 Azitromycin total dose 4.0 g 4.5 g 6.0 g Comparative drugs Ciprofloxacin Clarithromycin Doxycycline Antimicrobial treatment in 389 patients

21 Clinical efficacy and tolerability of administered drug as well as possible adverse events were evaluated during, at the end, and at 4-6 weeks of therapy completion. Clinical response definitions: Cure complete resolution of urethral, prostatic and sexual symptoms Improvement incomplete resolution of urethral, prostatic or sexual symptoms, but no need for additional therapy; and Failure no apparent response or progression of urethral, prostatic or sexual symptoms, or additional antibiotic therapy needed.

22 Bacteriologic efficacy of the administered drug was evaluated at 4-6 weeks of therapy completion using methods identical to those used on study enrolment. Bacteriologic response definitions: Eradication eradication of Chlamydia trachomatis or Ureaplasma urealyticum at post-treatment visit; and Persistence persistence of Chlamydia trachomatis or Ureaplasma urealyticum at post-treatment visit

23 Published papers Škerk V, Schönwald S, Krhen I, et al. Azithroymcin in the treatment of chronic prostatitis caused by Chlamydia trachomatis. J Chemother 2001;13: Škerk V, Schönwald S, Krhen I, et al. Comparative analysis of azithromycin and clarithromycin efficacy and tolerability in the treatment of chronic prostatitis caused by Chlamydia trachomatis. J Chemother 2001;14: Škerk V, Schönwald S, Krhen I, et al. Comparative analysis of azithromycin and ciprofloxacin in the treatment of chronic prostatitis caused by Chlamydia trachomatis. Int J Antimicrob Agents 2003;21: Škerk V, Krhen I, Lisić M, et al. Azithromycin: 4.5 or 6.0 gram dose in the treatment of patients with chronic prostatitis caused by Chlamydia trachomatis a randomized study. J Chemother 2004;16: Škerk V, Krhen I, Lisić M, et al. Comparative randomized pilot study of azithromycin and doxycycline efficacy in the treatment of prostate infection caused by Chlamydia trachomatis. Int J Antimicrob Agents 2004;24:

24 Published papers 6. Škerk V, Čajić V, Markovinović L, et al. Azithromycin in the treatment of prostatitis caused by U.urealyticum. Medicus 2006;15: Škerk V, Mareković I, Markovinović L, et al. Comparative randomized pilot study of azithromycin and doxycycline efficacy and tolerability in the treatment of prostate infection cuased by Ureaplasma urealyticum. Chemotherapy 2005;52: Škerk V, Markovinović L, Zekan S, et al. The significance of Chlamydia trachomatis in urethritis and prostatitis differences in therapeutic approach Croatian experience. J Chemotherapy Feb 2009 in press 9. Škerk V, Roglić S, Čajić V, et al. Comparison of clinical symptoms scored by the National Institutes of Health Chronic Prostatitis Symptoms Index (NIH-CPSI) and laboratory results for the assessment of clinical and bacteriological efficacy of antimicrobial treatment in patients with chronic prostatitis syndrome. J Chemotherapy Apr 2009 in press

25 Škerk V, Schönwald S, Krhen I i sur. Comparative analysis of azithromycin and clarithromycin efficacy and tolerability in the treatment of chronic prostatitis caused by Chlamydia trachomatis. J Chemother 2002;14: Bacteriological evaluation of azithromycin and clarithromycin efficacy in the treatment of patients with chronic prostatitis caused by Chlamydia trachomatis Bacteriological evaluation Antimicrobial treatment AZITHROMYCIN CLARITHROMYCIN 4.5 g / 3 weeks 2 x 500 mg / 15 days n (%) n %) Eradication 37 (80.43) 36 (80.00) Persistence 9 (19.57) 9 (20.00) T O T A L P=0,83

26 Škerk V, Schönwald S, Krhen I i sur. Comparative analysis of azithromycin and clarithromycin efficacy and tolerability in the treatment of chronic prostatitis caused by Chlamydia trachomatis. J Chemother 2002;14: Clinical evaluation of azithromycin and clarithromycin efficacy in the treatment of patients with chronic prostatitis caused by Chlamydia trachomatis Clinical evaluation Cure Failure Antimicrobial treatment AZITHROMYCIN CLARITHROMYCIN 4.5g / 3 weeks 2 x 500 mg / 15 days n (%) n (%) 32 (69.57) 14 (30.43) 32 (71.11) 13 (28.89) T O T A L P=0,946

27 Škerk V, Schönwald S, Krhen I i sur. Comparative analysis of azithromycin and ciprofloxacin in the treatment of chronic prostatitis caused by Chlamydia trachomatis. Int J Antimicrob Agents 2003;21: Bacteriological evaluation of azithromycin and ciprofloxacin efficacy in the treatment of chronic chlamydial prostatitis Efficacy P=0,0002 Patients treated with azithromycin (n=45) 36 (80%) 9 (20%) Patients treated with ciprofloxacin (n=44) 17 (38,64) 27 (61,36) Eradication Persistence TOTAL 45 44

28 Škerk V, Schönwald S, Krhen I i sur. Comparative analysis of azithromycin and ciprofloxacin in the treatment of chronic prostatitis caused by Chlamydia trachomatis. Int J Antimicrob Agents 2003;21: Clinical efficacy of azithromycin and ciprofloxacin in the treatment of chronic chlamydial prostatitis Efficacy Cure Improvement Failure P=0,0021 Patients treated with azithromycin (n=45) 31 (68, 89%) 4 (8,89%) 10 (22,22%) Patients treated with ciprofloxacin (n=44) 15 (34,09%) 7 (15,91%) 22 (50%) TOTAL 45 44

29 Škerk V, Krhen I, Lisić M i sur. Comparative randomized pilot study of azithromycin and doxycycline efficacy in the treatment of prostate infection caused by Chlamydia trachomatis. Int J Antimicrob Agents 2004;24: Bacteriological evaluation of azithromycin and doxycycline efficacy in the treatment of prostate infection caused by C. trachomatis Efficacy Patients treated with azithromycin (n=82) Patients treated with doxycycline (n=43) Eradication 65 (79,27%) 33 (76,74%) Persistence 17 (20,73%) 10 (23,26%) TOTAL P=0,82

30 Škerk V, Krhen I, Lisić M i sur. Comparative randomized pilot study of azithromycin and doxycycline efficacy in the treatment of prostate infection caused by Chlamydia trachomatis. Int J Antimicrob Agents 2004;24: Clinical efficacy of azithromycin and doxycycline in the treatment of prostate infection caused by C. trachomatis Efficacy Patients treated with azithromycin (n=82) Patients treated with doxycycline (n=43) Cure 56 (68,29%) 30 (69,77%) Improvement 3 (3,66%) 2 (4,65%) Failure 23 (28,05%) 11 (25,58%) TOTAL P=0,94

31 Comparison of the efficacy of different doses of azithromycin in the treatment of 307 patients with chronic chlamydial prostatitis EFFICACY AZITHROMYCIN n=82 4,0 g total 1x1g po. per week 4 weeks ANTIMICROBIAL THERAPY AZITHROMYCIN n=182 4,5 g total 1x500 mg po. 3 days per week 3 weeks AZITHROMYCIN n=43 6,0 g total 1x1g po per week 6 weeks BACTERIOLOGICAL ERADICAT ION 65 (79%) 151 (83%) 35 (81%) PERSISTENCE CLINICAL CURED 56 (68%) 124 (68%) 31 (72%) NOT CURED

32 Efficacy of azithromycin and doxycycline in the treatment of chronic prostatitis caused by U.urealyticum ANTIMICROBIAL THERAPY EFFICACY BACTERIOLOGICAL ERADICATION PERSISTENCE CLINICAL CURED NOT CURED AZITHROMYCIN n=32 4,5g total 1x500mg po. 3 days per week 3 weeks DOXYCYCLINE n=31 2x100mg po. 21 days P=0,77 P=1,0

33 CONCLUSION Azithromycin is an efficient and safe antimicrobial drug for the treatment of chronic prostatitis caused by C.trachomatis. It is recommended: In a total dose of 4.5 g po. during 3 weeks, administered for 3 days in doses 1x500mg per day OR In a total dose of 4.0 g po. during 4 weeks, administered in a single dose of 1x1.0 g per week

34 CONCLUSION Azithromycin is efficient and safe antimicrobial drug for the treatment of chronic prostatitis caused by U.urealyticum. It is recommended In a total dose of 4.5g po. during 3 weeks, administered for 3 days in dose 1x500mg per day

35

36

A Practical Guide to Diagnosis and Treatment of Infection in the Outpatient Setting Diagnosis and Treatment of Urinary Tract Infections

A Practical Guide to Diagnosis and Treatment of Infection in the Outpatient Setting Diagnosis and Treatment of Urinary Tract Infections A Practical Guide to Diagnosis and Treatment of Infection in the Outpatient Setting Diagnosis and Treatment of Urinary Tract Infections By Gary R. Skankey, MD, FACP, Infectious Disease, Las Vegas, NV Sponsored

More information

Diagnosis and Treatment of Prostatitis

Diagnosis and Treatment of Prostatitis Prostatic Diseases Diagnosis and Treatment of Prostatitis JMAJ 47(12): 561 565, 2004 Takashi DEGUCHI Professor, Department of Urology, Gifu University School of Medicine Abstract: Among various prostatic

More information

Prostatitis. What are the different types of prostatitis and their causes?

Prostatitis. What are the different types of prostatitis and their causes? Prostatitis What is prostatitis? Prostatitis is a condition that involves inflammation of the prostate and sometimes the area around it. There are several types of prostatitis, each with a range of symptoms.

More information

Chronic Prostatitis and Chronic Pelvic Pain Syndrome

Chronic Prostatitis and Chronic Pelvic Pain Syndrome Chronic and Chronic Pelvic Pain Syndrome PROSTATITIS is a clinical syndrome. It afflicts men as early as twenty (20) years of age up to as late as 70 years and older. There are four major signs and symptoms:

More information

Urinary Tract Infections

Urinary Tract Infections Urinary Tract Infections Overview A urine culture must ALWAYS be interpreted in the context of the urinalysis and patient symptoms. If a patient has no signs of infection on urinalysis, no symptoms of

More information

GUIDELINES ON UROLOGICAL INFECTIONS

GUIDELINES ON UROLOGICAL INFECTIONS GUIDELINES ON UROLOGICAL INFECTIONS (Text update April 2014) M. Grabe (chair), R. Bartoletti, T.E. Bjerklund-Johansen, M. Çek, K.G. Naber, R.S. Pickard, P. Tenke, F. Wagenlehner, B. Wullt Introduction

More information

GUIDELINES ON UROLOGICAL INFECTIONS

GUIDELINES ON UROLOGICAL INFECTIONS GUIDELINES ON UROLOGICAL INFECTIONS (Text update April 2010) M. Grabe (chairman), T.E. Bjerklund-Johansen, H. Botto, M. Çek, K.G. Naber, R.S. Pickard, P. Tenke, F. Wagenlehner, B. Wullt Introduction Infections

More information

Pharmacist Prescribing for UTI: The Burning Question of Self Diagnosis

Pharmacist Prescribing for UTI: The Burning Question of Self Diagnosis for UTI: The Burning Question of Self Diagnosis Overview Review Pharmacist prescribing in Saskatchewan Discuss current management / diagnosis of UTI Appraise the literature for safe and accurate diagnosis

More information

URINARY TRACT INFECTIONS TO TREAT OR NOT TO TREAT

URINARY TRACT INFECTIONS TO TREAT OR NOT TO TREAT URINARY TRACT INFECTIONS TO TREAT OR NOT TO TREAT Eddie Grace, Pharm.D.,BCPS,AQ-ID, AAHIVE Associate Professor of Pharmacy Practice Presbyterian College School of Pharmacy October 20 th, 2011 Objectives

More information

University Hospital for Infectious Diseases Dr. Fran Mihaljević, Zagreb, Croatia 2. Royal Free Hospital & JUSTRI London, UK

University Hospital for Infectious Diseases Dr. Fran Mihaljević, Zagreb, Croatia 2. Royal Free Hospital & JUSTRI London, UK Š. Zekan 1, M. Youle 2, O. Đaković Rode 1, S. Židovec Lepej 1, M. Kosanović 1, J. Begovac 1 1 University Hospital for Infectious Diseases Dr. Fran Mihaljević, Zagreb, Croatia 2 Royal Free Hospital & JUSTRI

More information

Prostatitis and male UTI

Prostatitis and male UTI Prostatitis Common Most common urological problem in men < 50 yrs Third most common problem in men > 50yrs Represents 3% to 12% of male outpatient visits to urologists All ages affected Worldwide distribution

More information

Title: Antibiotic Guideline for Acute Pelvic Inflammatory Disease

Title: Antibiotic Guideline for Acute Pelvic Inflammatory Disease Title: Antibiotic Guideline for Acute Pelvic Inflammatory Disease Version 3 Date ratified December 2007 Review date December 2009 Ratified by NUH Antimicrobial Guidelines Committee Gynaecology Directorate

More information

Catheter-Associated Urinary Tract Infection (CAUTI) Event

Catheter-Associated Urinary Tract Infection (CAUTI) Event Catheter-Associated Urinary Tract Infection () Event Introduction: Urinary tract infections (UTIs) are tied with pneumonia as the second most common type of healthcare-associated infection, second only

More information

STI case management. Francis Ndowa - GFMER Theodora Wi - WHO

STI case management. Francis Ndowa - GFMER Theodora Wi - WHO Training Course in Sexual and Reproductive Health Research 2014 Module: Principles and Practice of Sexually Transmitted Infections Prevention and Care STI case management Francis Ndowa - GFMER Theodora

More information

Male Chronic pelvic pain syndrome. Dr. Kan Chi Fai Associate Consultant Queen Elizabeth Hospital

Male Chronic pelvic pain syndrome. Dr. Kan Chi Fai Associate Consultant Queen Elizabeth Hospital Male Chronic pelvic pain syndrome Dr. Kan Chi Fai Associate Consultant Queen Elizabeth Hospital What patient groups are included in Prostatitis? this topic? Patients with perineal pain? Patients with LUTS?

More information

THIS IS AN OFFICIAL NH DHHS HEALTH ALERT

THIS IS AN OFFICIAL NH DHHS HEALTH ALERT THIS IS AN OFFICIAL NH DHHS HEALTH ALERT Distributed by the NH Health Alert Network Health.Alert@nh.gov August 13, 2015 1400 EDT (2:00 PM EDT) NH-HAN 20150813 Updated Centers for Disease Control (CDC)

More information

signs suggesting chlamydia:

signs suggesting chlamydia: Chlamydia - uncomplicated genital - Management View full scenario When should I suspect and test for chlamydia? Women: o Test for chlamydia if they are sexually active with symptoms and signs suggesting

More information

A PRINTED copy of this guideline may not be the most recent version. The OFFICIAL version is located on IHNET at the Policies & Procedures Home Page

A PRINTED copy of this guideline may not be the most recent version. The OFFICIAL version is located on IHNET at the Policies & Procedures Home Page A PRINTED copy of this guideline may not be the most recent version. The OFFICIAL version is located on IHNET at the Policies & Procedures Home Page IX0200: Prevention & Control of Catheter Associated

More information

Tamsulosin Treatment of Chronic Non-bacterial Prostatitis

Tamsulosin Treatment of Chronic Non-bacterial Prostatitis The Journal of International Medical Research 2008; 36: 244 252 Tamsulosin Treatment of Chronic Non-bacterial Prostatitis ZQ YE, RZ LAN, WM YANG, LF YAO AND X YU Department of Urology, Tongji Hospital,

More information

Difference on the Incidence of Urinary Tract Infection (UTI) between Diabetic and Non-diabetic Women Admitted in Metro Cebu, Philippines

Difference on the Incidence of Urinary Tract Infection (UTI) between Diabetic and Non-diabetic Women Admitted in Metro Cebu, Philippines Mindanao Journal of Science and Technology Vol. 12 (2014) 171-178 Difference on the Incidence of Urinary Tract Infection (UTI) between Diabetic and Non-diabetic Women Admitted in Metro Cebu, Philippines

More information

Frequently Asked Questions

Frequently Asked Questions Guidelines for Testing and Treatment of Gonorrhea in Ontario, 2013 Frequently Asked Questions Table of Contents Background... 1 Treatment Recommendations... 2 Treatment of Contacts... 4 Administration

More information

The Treatment ofnon-gonococcal Urethritis with Single Dose Oral Azithromycin

The Treatment ofnon-gonococcal Urethritis with Single Dose Oral Azithromycin The Journal of International Medical Research 1995; 23: 386-393 The Treatment ofnon-gonococcal Urethritis with Single Dose Oral Azithromycin T ERDOGRU\ A AGA9FIDAff, M ONELz,S BADUR z, 0 ANG 2 AND S TELALLOGLU

More information

Microbiology AN INTRODUCTION EIGHTH EDITION

Microbiology AN INTRODUCTION EIGHTH EDITION Copyright 2004 Pearson Education, Inc., publishing as Benjamin Cummings TORTORA FUNKE CASE Microbiology AN INTRODUCTION EIGHTH EDITION Chapter 26 PowerPoint Lecture Slide Presentation prepared by Christine

More information

Background: U.S. Estimates. Edward W. Hook, III, M.D. The Medical Value of Laboratory Testing for STI Management

Background: U.S. Estimates. Edward W. Hook, III, M.D. The Medical Value of Laboratory Testing for STI Management Edward W. Hook, III, M.D. The Medical Value of Laboratory Edward W. Hook III M.D. Departments of Medicine. Microbiology and Epidemiology University of Alabama at Birmingham Grant/Research Support: Consultant:

More information

Summary ORIGINAL PAPER. Konstantinos Stamatiou, Nikolaos Pierris

Summary ORIGINAL PAPER. Konstantinos Stamatiou, Nikolaos Pierris ORIGINAL PAPER DOI: 10.4081/aiua.2013.4.190 Serenoa repens extract additionally to quinolones in the treatment of chronic bacterial prostatitis. The preliminary results of a long term observational study

More information

Expedited Partner Therapy (EPT) for Sexually Transmitted Diseases Protocol for Health Care Providers in Oregon

Expedited Partner Therapy (EPT) for Sexually Transmitted Diseases Protocol for Health Care Providers in Oregon Expedited Partner Therapy (EPT) for Sexually Transmitted Diseases Protocol for Health Care Providers in Oregon Oregon Health Authority Center for Public Health Practice HIV/STD/TB Section Principles of

More information

Adult Inclusion Conjunctivitis

Adult Inclusion Conjunctivitis Adult Inclusion Conjunctivitis Dr. Victor Malinovsky 2006 General Characteristics Chlamydia are obligate intracellular parasites, C. trachomatis causes inclusion conjunctivitis, trachoma, cervicitis (women)

More information

Chronic Prostatitis: Patient information

Chronic Prostatitis: Patient information Chronic Prostatitis: Patient information There are two main types of chronic prostatitis - chronic bacterial prostatitis (caused by chronic bacterial infection) and chronic prostatitis/chronic pelvic pain

More information

Case Studies in Urinary Tract Infections

Case Studies in Urinary Tract Infections Case Studies in Urinary Tract Infections Robert L. Holley, MSc, MD Professor of Obstetrics and Gynecology Division of Urogynecology and Pelvic Reconstructive Surgery Department of Obstetrics and Gynecology

More information

Urinary Tract Infections

Urinary Tract Infections Urinary Tract Infections Leading cause of morbidity and health care expenditures in persons of all ages. An estimated 50 % of women report having had a UTI at some point in their lives. 8.3 million office

More information

How to Make Adolescent STD Screening Easy. Jill Grimes, MD

How to Make Adolescent STD Screening Easy. Jill Grimes, MD How to Make Adolescent STD Screening Easy Jill Grimes, MD Disclaimer This presentation reflects the opinions of Jill Grimes, MD, and is not intended to represent the opinions of the Seton family of hospitals.

More information

NICE Pathways bring together all NICE guidance, quality standards and other NICE information on a specific topic.

NICE Pathways bring together all NICE guidance, quality standards and other NICE information on a specific topic. Initial assessment and investigation of urinary incontinence bring together all NICE guidance, quality standards and other NICE information on a specific topic. are interactive and designed to be used

More information

Management of culture positive urinary tract infections. Sri Lanka Journal of Child Health, 2016; 45(3):

Management of culture positive urinary tract infections. Sri Lanka Journal of Child Health, 2016; 45(3): Management of culture positive urinary tract infections in children aged 0-16 years: An audit conducted in a District General Hospital in the United Kingdom *S Jeyabalan 1, E. Ikpakwu 2, G Liyanage 3 Sri

More information

Frequently Asked Questions

Frequently Asked Questions Frequently Asked Questions Testing for Gonorrhea Q1: What test should be completed for accurately diagnosing gonorrhea? A1: Testing is done with either a culture or a NAAT (nucleic acid amplification test).

More information

Painful Micturition and Increased Frequency of Micturition

Painful Micturition and Increased Frequency of Micturition C H A P T E R Painful Micturition and Increased Frequency of Micturition 1 1 Patients may complain of a painful or burning sensation when they pass urine or may tell you that the number of times that they

More information

Sexually Transmitted Diseases. Summary of CDC Treatment Guidelines

Sexually Transmitted Diseases. Summary of CDC Treatment Guidelines DC 2015 Sexually Transmitted Diseases Summary of CDC Treatment Guidelines These summary guidelines reflect the June 2015 update to the 2010 CDC Guidelines for Treatment of Sexually Transmitted Diseases.

More information

Semen analysis in chronic bacterial prostatitis: diagnostic and therapeutic implications

Semen analysis in chronic bacterial prostatitis: diagnostic and therapeutic implications Original Article Asian Journal of Andrology (2009) 11: 461 477 2009 AJA, SIMM & SJTU All rights reserved 1008-682X/09 $ 32.00 www.nature.com/aja : diagnostic and therapeutic implications 461 Vittorio Magri

More information

Treatment of Urinary Tract Infections in Geriatric Patients

Treatment of Urinary Tract Infections in Geriatric Patients Treatment of Urinary Tract Infections in Geriatric Patients Spencer H. Durham, Pharm.D.,BCPS (AQ-ID) Assistant Clinical Professor Department of Pharmacy Practice Auburn University Harrison School of Pharmacy

More information

GLOBAL OVERVIEW OF ANTIMICROBIAL RESISTANCE STD AGENTS

GLOBAL OVERVIEW OF ANTIMICROBIAL RESISTANCE STD AGENTS GLOBAL OVERVIEW OF ANTIMICROBIAL RESISTANCE STD AGENTS IN Dr.P.Bhalla Director Professor and Head Dept. of Microbiology Maulana Azad Medical College New Delhi, INDIA STDs & RTIs l HIV l Gonococcal infections/

More information

STD Section Services for Providers and Gonorrhea Update

STD Section Services for Providers and Gonorrhea Update STD Section Services for Providers and Gonorrhea Update Susan Philip, MD MPH Director, STD Prevention and Control Services San Francisco Department of Public Health Assistant Clinical Professor of Medicine

More information

Sexually Transmitted Infections Chlamydia and Gonorrhea Infection Control Education Sessions Bug of the Month

Sexually Transmitted Infections Chlamydia and Gonorrhea Infection Control Education Sessions Bug of the Month Sexually Transmitted Infections Chlamydia and Gonorrhea Infection Control Education Sessions Bug of the Month Dr. Shauna Hudson, Medical Health Officer Lindsay Bowman, Communicable Disease/Immunization

More information

CDC 2015 STD Treatment Guidelines: Update for IHS Providers Sharon Adler M.D., M.P.H.

CDC 2015 STD Treatment Guidelines: Update for IHS Providers Sharon Adler M.D., M.P.H. CDC 2015 STD Treatment Guidelines: Update for IHS Providers Sharon Adler M.D., M.P.H. Clinical Faculty, CA Prevention Training Center Disclosure Information Sharon Adler MD, MPH I have no financial relationships

More information

Penile pain- What s wrong, doc? Lincoln Tan Registrar

Penile pain- What s wrong, doc? Lincoln Tan Registrar Penile pain- What s wrong, doc? Lincoln Tan Registrar The Good Penile pain associated with symptoms or signs consistent with common causes e.g STDs, UTIs The Bad Chronic penile pain without other features

More information

Medical microbiology is the study of interactions between humans and microorganisms such as bacteria, viruses, fungi and parasites.

Medical microbiology is the study of interactions between humans and microorganisms such as bacteria, viruses, fungi and parasites. Commensal and Pathogenic Microbial Flora in Humans Medical microbiology is the study of interactions between humans and microorganisms such as bacteria, viruses, fungi and parasites. Although the primary

More information

Antibiotic Prophylaxis for Short-term Catheter Bladder Drainage in adults. A Systematic Review (Cochrane database August 2013)

Antibiotic Prophylaxis for Short-term Catheter Bladder Drainage in adults. A Systematic Review (Cochrane database August 2013) Antibiotic Prophylaxis for Short-term Catheter Bladder Drainage in adults A Systematic Review (Cochrane database August 2013) Gail Lusardi, Senior Lecturer Dr Allyson Lipp, Principal Lecturer, Dr Chris

More information

GONORRHOEA. Use of lidocaine as a diluent when using ceftriaxone (see Appendix 1)

GONORRHOEA. Use of lidocaine as a diluent when using ceftriaxone (see Appendix 1) Key practice notes: 1 st line therapy GONORRHOEA Decreasing sensitivity of gonorrhoea to cephalosporins is now a real threat: CEFTRIAXONE 500mg IM stat first-line for all gonococcal infections AZITHROMYCIN

More information

Bacterial Classification and Disease

Bacterial Classification and Disease Bacterial Classification and Disease Purpose To provide an overview of how physicians think when confronted with a bacterial infection To alert you to the importance of bacterial classification in treatment

More information

Treatment of sexually transmitted and other genital infections

Treatment of sexually transmitted and other genital infections www.bpac.org.nz keyword: sti Treatment of sexually transmitted and other genital infections Key reviewer: Dr Murray Reid, Sexual Health Physician, Auckland Sexual Health Service General points: If one

More information

Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline

Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline QUICK REFERENCE GUIDE Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline Jon Rees, 1 Mark Abrahams, 2 Victor Abu, 3 Trevor

More information

Phase I Study Results

Phase I Study Results Phase I Study Results Super-strength, freeze-dried Aloe vera capsules for interstitial cystitis, painful bladder syndrome, chronic pelvic pain, and nonbacterial prostatitis Czarapata, B. J. (1995, October).

More information

A Summary of the Guideline for the Diagnosis and Management of. Urinary Tract Infections in Long Term Care

A Summary of the Guideline for the Diagnosis and Management of. Urinary Tract Infections in Long Term Care A Summary of the Guideline for the Diagnosis and Management of Urinary Tract Infections in Long Term Care Exclusions Community acquired UTIs UTIs in acute care Prevention Limit use of catheters Ensure

More information

Homeopathic Treatment of Urethritis. Thomas A. Kruzel, N. D.

Homeopathic Treatment of Urethritis. Thomas A. Kruzel, N. D. Homeopathic Treatment of Urethritis Thomas A. Kruzel, N. D. Urethritis or inflammation of the urethra (the tube leading from the bladder to the outside of the body) is a very common condition. Physicians

More information

A THREE YEAR REVIEW OF CATHETER-ASSOCIATED URINARY TRACT INFECTIONS REPORTED TO THE NATIONAL HEALTHCARE SAFETY NETWORK AT A TERTIARY CARE HOSPITAL

A THREE YEAR REVIEW OF CATHETER-ASSOCIATED URINARY TRACT INFECTIONS REPORTED TO THE NATIONAL HEALTHCARE SAFETY NETWORK AT A TERTIARY CARE HOSPITAL A THREE YEAR REVIEW OF CATHETER-ASSOCIATED URINARY TRACT INFECTIONS REPORTED TO THE NATIONAL HEALTHCARE SAFETY NETWORK AT A TERTIARY CARE HOSPITAL by Jessi Marie Bond BS, Clinical Laboratory Science, Idaho

More information

Detection of Urinary Tract Infections by Rapid Methods

Detection of Urinary Tract Infections by Rapid Methods CLINICAL MICROBIOLOGY REVIEWS, JUly 1988, p. 268-280 Vol. 1, No. 2 0893-8512/88/030268-13$02.00/0 Copyright C) 1988, American Society for Microbiology Detection of Urinary Tract Infections by Rapid Methods

More information

Antibiotics in sepsis

Antibiotics in sepsis Antibiotics in sepsis Jennifer Curello, PharmD, BCPS Antimicrobial Stewardship Program Ronald Reagan UCLA Medical Center September 13, 2013 Outline Sepsis definitions The sepsis bundle Timing of antimicrobials

More information

TREATMENT OF STI CONTACTS

TREATMENT OF STI CONTACTS This decision support tool is effective as of October 2014. For more information or to provide feedback on this or any other decision support tool, email certifiedpractice@crnbc.ca TREATMENT OF STI CONTACTS

More information

SURGICAL PROPHYLAXIS: ANTIBIOTIC RECOMMENDATIONS FOR ADULT PATIENTS

SURGICAL PROPHYLAXIS: ANTIBIOTIC RECOMMENDATIONS FOR ADULT PATIENTS Page 1 of 8 TITLE: SURGICAL PROPHYLAXIS: ANTIBIOTIC RECOMMENDATIONS FOR ADULT PATIENTS GUIDELINE: Antibiotics are administered prior to surgical procedures to prevent surgical site infections. PURPOSE:

More information

PSA Screening for Prostate Cancer Information for Care Providers

PSA Screening for Prostate Cancer Information for Care Providers All men should know they are having a PSA test and be informed of the implications prior to testing. This booklet was created to help primary care providers offer men information about the risks and benefits

More information

Catheter-Associated Urinary Tract Infections (CAUTI): A partnership in care. Dr. Louise Hobbs Manager IPSS Melbourne Health

Catheter-Associated Urinary Tract Infections (CAUTI): A partnership in care. Dr. Louise Hobbs Manager IPSS Melbourne Health Catheter-Associated Urinary Tract Infections (CAUTI): A partnership in care Dr. Louise Hobbs Manager IPSS Melbourne Health Why CAUTI? Standard 3 Invasive Device October 2012 Most common type of device

More information

Age in years Females (% prevalence) Males (% prevalence) 6-15 Vesicoureteral reflux (4.4%) Vesicoureteral reflux (0.5%)

Age in years Females (% prevalence) Males (% prevalence) 6-15 Vesicoureteral reflux (4.4%) Vesicoureteral reflux (0.5%) Magdalena E. Sobieszczyk Urinary Tract Infections AIMS: 1. Understand epidemiology and microbiology of urinary tract infections 2. Understand pathogenesis of lower and upper urinary tract infections 3.

More information

Ground K 1, Jones W 2, Gahm G 3, Drake C 2, Min S-J 2, Trautner B 4, Wald HL 2

Ground K 1, Jones W 2, Gahm G 3, Drake C 2, Min S-J 2, Trautner B 4, Wald HL 2 Ground K 1, Jones W 2, Gahm G 3, Drake C 2, Min S-J 2, Trautner B 4, Wald HL 2 1 Duke University Hospital, 2 University of Colorado School of Medicine, 3 Vivage, 4 Baylor College of Medicine/Houston VA

More information

The Minnesota Chlamydia Strategy: Action Plan to Reduce and Prevent Chlamydia in Minnesota Minnesota Chlamydia Partnership, April 2011

The Minnesota Chlamydia Strategy: Action Plan to Reduce and Prevent Chlamydia in Minnesota Minnesota Chlamydia Partnership, April 2011 The Minnesota Chlamydia Strategy: Action Plan to Reduce and Prevent Chlamydia in Minnesota Minnesota Chlamydia Partnership, April 2011 Section 5: Screening, Treating and Reporting Chlamydia While the information

More information

Fungal Infection in Total Joint Arthroplasty. Dr.Wismer Dr.Al-Sahan

Fungal Infection in Total Joint Arthroplasty. Dr.Wismer Dr.Al-Sahan Fungal Infection in Total Joint Arthroplasty Dr.Wismer Dr.Al-Sahan Delayed Reimplantation Arthroplasty for Candidal Prosthetic Joint Infection: A Report of 4 Cases and Review of the Literature David M.

More information

Specimen collection and transport for Chlamydia trachomatis and Neisseria gonorrhoeae testing

Specimen collection and transport for Chlamydia trachomatis and Neisseria gonorrhoeae testing Specimen collection and transport for Chlamydia trachomatis and Neisseria gonorrhoeae testing Overview Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infections are two of the most common sexually

More information

ANTIBIOTICS FROM HEAD TO TOE: PART 5 - URINARY TRACT INFECTIONS LAUREN HYNICKA, PHARM.D.

ANTIBIOTICS FROM HEAD TO TOE: PART 5 - URINARY TRACT INFECTIONS LAUREN HYNICKA, PHARM.D. ANTIBIOTICS FROM HEAD TO TOE: PART 5 - URINARY TRACT INFECTIONS LAUREN HYNICKA, PHARM.D. ANTIBIOTICS FROM HEAD TO TOE: PART 5 - URINARY TRACT INFECTIONS ACTIVITY DESCRIPTION Antibiotic use in the safest

More information

Antibacterial perineal wash as prophylaxis for recurrent urinary tract infections in a female pediatric population

Antibacterial perineal wash as prophylaxis for recurrent urinary tract infections in a female pediatric population Melissa Laudano Protocol Submission, ICCR Rotation August 6, 2007 Antibacterial perineal wash as prophylaxis for recurrent urinary tract infections in a female pediatric population A. Study Purpose and

More information

GUIDELINES ON UROLOGICAL INFECTIONS

GUIDELINES ON UROLOGICAL INFECTIONS GUIDELINES ON UROLOGICAL INFECTIONS (Limited text update March 2015) M. Grabe (Chair), R. Bartoletti, T.E. Bjerklund Johansen, M. Çek, B. Köves (Guidelines Associate), K.G. Naber, R.S. Pickard, P. Tenke,

More information

Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline

Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline Jon Rees, 1 Mark Abrahams, 2 Victor Abu, 3 Trevor Allan, 4 Andrew Doble,

More information

GONORRHEA (REPORTABLE)

GONORRHEA (REPORTABLE) This decision support tool is effective as of February 2014. For more information or to provide feedback on this or any other decision support tool, email certifiedpractice@crnbc.ca GONORRHEA (REPORTABLE)

More information

M I C R O B I O L O G Y WITH DISEASES BY BODY SYSTEM SECOND EDITION

M I C R O B I O L O G Y WITH DISEASES BY BODY SYSTEM SECOND EDITION Chapter 24 M I C R O B I O L O G Y WITH DISEASES BY BODY SYSTEM SECOND EDITION Microbial Diseases of the Urinary and Reproductive Systems 1 Topic 19: Microbial Diseases of the Urinary and Reproductive

More information

Urinary Tract Infections

Urinary Tract Infections Urinary Tract Infections Magdalena Sobieszczyk, MD MPH Division of Infectious Diseases Columbia University Clinical Scenario #1 23 y.o woman presents to her doctor complaining of 1 day of increased urinary

More information

SPECIMEN COLLECTION GUIDE USER GUIDE FOR SPECIMEN COLLECTION

SPECIMEN COLLECTION GUIDE USER GUIDE FOR SPECIMEN COLLECTION SPECIMEN COLLECTION GUIDE USER GUIDE FOR SPECIMEN COLLECTION MICROBIOLOGY AND MOLECULAR DIAGNOSTIC SERVICES ACM Medical Laboratory offers a comprehensive menu of Microbiology and Molecular Diagnostic services

More information

Prostatitis is frequently diagnosed by urologists and primary

Prostatitis is frequently diagnosed by urologists and primary PROSTATITIS SYMPTOM INDEX Development and Use of a Validated Outcome Measure for Chronic Prostatitis J. Curtis Nickel, MD, FRCSC, Mary McNaughton Collins, MD, MPH, and Mark S. Litwin, MD, MPH Prostatitis

More information

Treatment of Chronic Prostatitis and Prostatodynia with Pollen Extract

Treatment of Chronic Prostatitis and Prostatodynia with Pollen Extract Treatment of Chronic Prostatitis and Prostatodynia with Pollen Extract A. C. Buck, R. W. M. Rees, L. Ebeling * Published in Brit.J. Urol. 64 (1989) 496-499 The treatment of chronic, relapsing nonbacterial

More information

THE UNITED REPUBLIC OF TANZANIA MINISTRY OF HEALTH AND SOCIAL WELFARE

THE UNITED REPUBLIC OF TANZANIA MINISTRY OF HEALTH AND SOCIAL WELFARE THE UNITED REPUBLIC OF TANZANIA Treat for Lymphogranuloma venereum MINISTRY OF HEALTH AND SOCIAL WELFARE Appoint to return after Patient complains of Use Discharge from Continue to 2nd Refer to surgeon

More information

Urinary Tract Infections. Clinical Scenario #1. Urinary Tract Infections. Clinical Scenario #1 : Labs

Urinary Tract Infections. Clinical Scenario #1. Urinary Tract Infections. Clinical Scenario #1 : Labs Clinical Scenario #1 : Labs Urinary Tract Infections Magdalena Sobieszczyk, MD Urinalysis: pyuria (WBC too numerous to count), RBC and bacteria present Urine dipstick: positive leukocyte esterase and nitrite

More information

The Prostate Owner s Manual

The Prostate Owner s Manual The Prostate Owner s Manual F A C T S H E E T What you Should Know about the Prostate Only men have a prostate. A part of the male reproductive system, the prostate is located just below the bladder. It

More information

Don t Go With The Flow! Control and Management of UTIs in the Elderly

Don t Go With The Flow! Control and Management of UTIs in the Elderly Don t Go With The Flow! Control and Management of UTIs in the Elderly Acknowledgements Central West Infection Control Network Toronto Central Infection Control Network Erie St Clair Infection Control Network

More information

Changes in the 2010 STD Treatment Guidelines: What Adolescent Health Care Providers Should Know February 2011

Changes in the 2010 STD Treatment Guidelines: What Adolescent Health Care Providers Should Know February 2011 Changes in the 2010 STD Treatment Guidelines: What Adolescent Health Care Providers Should Know February 2011 Gale Burstein, MD, MPH, FAAP, FSAHM 1 Amanda Jacobs, MD, FAAP, 2 Dmitry Kissin, MD, MPH, 3

More information

MIBIE Summer School 2014. Molecular diagnostics of UTI & STI by using PCR, DHPLC and NGS

MIBIE Summer School 2014. Molecular diagnostics of UTI & STI by using PCR, DHPLC and NGS MIBIE Summer School 2014 Molecular diagnostics of UTI & STI by using PCR, DHPLC and NGS Eugen Domann Institute for Medical Microbiology Justus-Liebig University Gießen Human microbiome 14 Superorganism

More information

UTI s in Adults. Urinary Tract Infections. UTI - Definitions. Asymptomatic Women Voided vs. Catheterized Specimen. Symptomatic Women Suprapubic Tap

UTI s in Adults. Urinary Tract Infections. UTI - Definitions. Asymptomatic Women Voided vs. Catheterized Specimen. Symptomatic Women Suprapubic Tap Urinary Tract Infections Symptomatic and asymptomatic UTI s are a common problem > 10 million office visits per year > 1 million hospital admissions per year Cause of significant nosocomial morbidity Affects

More information

POTENTIAL FOR USE OF DEVICES RESONANSVÅG THERAPY, "AQUATONE" For complex treatment of chronic prostatitis.

POTENTIAL FOR USE OF DEVICES RESONANSVÅG THERAPY, AQUATONE For complex treatment of chronic prostatitis. POTENTIAL FOR USE OF DEVICES RESONANSVÅG THERAPY, "AQUATONE" For complex treatment of chronic prostatitis. ONE. Rossolovsky, S.V. Vlaskin, S.A. Dubovitsky, V.I. Petrosyan, B.I. Blumberg, D.N Khotko, A.I.

More information

Use of prostatic massage in combination with antibiotics in the treatment of chronic prostatitis

Use of prostatic massage in combination with antibiotics in the treatment of chronic prostatitis Use of prostatic massage in combination with antibiotics in the treatment of chronic prostatitis Prostate Cancer and Prostatic Diseases (1999) 2, 159±163 ß 1999 Stockton Press All rights reserved 1365±7852/99

More information

Beryl Navti SEPT Pharmacy Department. 24/06/2013 Beryl Navti, Clinical Pharmacist, SEPT

Beryl Navti SEPT Pharmacy Department. 24/06/2013 Beryl Navti, Clinical Pharmacist, SEPT URINARY TRACT INFECTIONS Beryl Navti SEPT Pharmacy Department The Genitourinary System The organs system of the reproductive organs and urinary system Grouped dtogether th because of their proximity it

More information

TO SEND OR NOT TO SEND? THE ROLE OF URINE CULTURES IN UNCOMPLICATED UTI. Patricia Moriarty, MSN, FNP-BC, APRN June 3, 2016

TO SEND OR NOT TO SEND? THE ROLE OF URINE CULTURES IN UNCOMPLICATED UTI. Patricia Moriarty, MSN, FNP-BC, APRN June 3, 2016 TO SEND OR NOT TO SEND? THE ROLE OF URINE CULTURES IN UNCOMPLICATED UTI Patricia Moriarty, MSN, FNP-BC, APRN June 3, 2016 OBJECTIVES 1. List the indications for a urine culture. 2. Define an uncomplicated

More information

Chlamydia THE FACTS. How do people get Chlamydia?

Chlamydia THE FACTS. How do people get Chlamydia? What is Chlamydia? Chlamydia is a common bacterial infection that is sexually transmitted and often causes no symptoms. If not treated, chlamydia can damage reproductive organs and make it difficult for

More information

Could bacteriuria hold the key to understanding urgency/ urge incontinence

Could bacteriuria hold the key to understanding urgency/ urge incontinence Could bacteriuria hold the key to understanding urgency/ urge incontinence 8:15 to 8:20min: Prof Kate Moore, introduction and welcome 8:20-8:35: Dr Colin Walsh 8:35-8:45: Discussion 8:45-9.00: Dr Kylie

More information

CHLAMYDIA CERVICITIS/URETHRITIS AND NON-GONOCOCCAL URETHRITIS (NGU)

CHLAMYDIA CERVICITIS/URETHRITIS AND NON-GONOCOCCAL URETHRITIS (NGU) CHLAMYDIA CERVICITIS/URETHRITIS AND NON-GONOCOCCAL URETHRITIS (NGU) DEFINITION SUBJECTIVE Infection of the cervix or urethra with Chlamydia trachomatis (CT). Chlamydia infection is a leading cause of acute

More information

2. Characteristics of staff Qualifications required. Additional requirements. Continued education & training requirements

2. Characteristics of staff Qualifications required. Additional requirements. Continued education & training requirements Patient Group Direction The supply of Azithromycin 1g as a single dose by accredited Community Pharmacists to patients in receipt of a positive test result to Chlamydia trachomatis, and treatment of their

More information

Prostatitis. Geoffrey F. Joyce, PhD Economist RAND Health, Santa Monica, California

Prostatitis. Geoffrey F. Joyce, PhD Economist RAND Health, Santa Monica, California C H A P T E R 1 Prostatitis Mary McNaughton-Collins, MD, MPH Assistant Professor of Medicine Harvard Medical School Massachusetts General Hospital Boston, Massachusetts Geoffrey F. Joyce, PhD Economist

More information

PERTUSSIS SURVEILLANCE AND RESPONSE PROTOCOL

PERTUSSIS SURVEILLANCE AND RESPONSE PROTOCOL PERTUSSIS SURVEILLANCE AND RESPONSE PROTOCOL Public Health Action 1. Educate the public, particularly parents of infants, about the dangers of whooping cough and the advantages of initiating immunization

More information

Safety and efficacy of levofloxacin versus ciprofloxacin for the treatment of chronic bacterial prostatitis in Chinese patients

Safety and efficacy of levofloxacin versus ciprofloxacin for the treatment of chronic bacterial prostatitis in Chinese patients (2012) 14, 870 874 ß 2012 AJA, SIMM & SJTU. All rights reserved 1008-682X/12 $32.00 www.nature.com/aja ORIGINAL ARTICLE Safety and efficacy of levofloxacin versus ciprofloxacin for the treatment of chronic

More information

COLONIZATION AND INFECTION CAUSED BY EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL)- PRODUCING ESCHERICHIA COLI IN NEUTROPENIC CANCER PATIENTS

COLONIZATION AND INFECTION CAUSED BY EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL)- PRODUCING ESCHERICHIA COLI IN NEUTROPENIC CANCER PATIENTS COLONIZATION AND INFECTION CAUSED BY EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL)- PRODUCING ESCHERICHIA COLI IN NEUTROPENIC CANCER PATIENTS Principal investigator: Dr Francesc Gudiol Munté Bellvitge University

More information

SULFONAMIDES SULFONAMIDES TREATMENT OF URINARY TRACT INFECTIONS TREATMENT OF URINARY TRACT INFECTIONS DRUGS USED TO TREAT UTI S

SULFONAMIDES SULFONAMIDES TREATMENT OF URINARY TRACT INFECTIONS TREATMENT OF URINARY TRACT INFECTIONS DRUGS USED TO TREAT UTI S TREATMENT OF URINARY TRACT INFECTIONS Most acute lower urinary tract infections (acute bacterial cystitis) are uncomplicated. E.coli causes 75-90% of episodes of acute uncomplicated cystitis. Staph saprophyticus

More information

Urinary Tract Infection Update Kim Gibson, MD Joseph Toscano, MD

Urinary Tract Infection Update Kim Gibson, MD Joseph Toscano, MD 82 Urinary Tract Infection Update Kim Gibson, MD Joseph Toscano, MD Abstract Urinary tract infections are commonly treated in urgent care practice. Clinicians need to be aware of the advantages and limitations

More information

National Chlamydia Screening Programme September 2012 PATIENT GROUP DIRECTION FOR THE ADMINISTRATION OF AZITHROMYCIN FOR CHLAMYDIA TRACHOMATIS

National Chlamydia Screening Programme September 2012 PATIENT GROUP DIRECTION FOR THE ADMINISTRATION OF AZITHROMYCIN FOR CHLAMYDIA TRACHOMATIS PATIENT GROUP DIRECTION FOR THE ADMINISTRATION OF AZITHROMYCIN FOR CHLAMYDIA TRACHOMATIS Below is a template that can be used to produce a local patient group direction (PGD) for the administration of

More information

STD Treatment Chart Nancy Harris, N.P. Women s Health Coordinator August 2003 Disease Treatment Alternative treatment

STD Treatment Chart Nancy Harris, N.P. Women s Health Coordinator August 2003 Disease Treatment Alternative treatment STD Treatment Chart Nancy Harris, N.P. Women s Health Coordinator August 2003 Disease Treatment Alternative Pregnancy Chlamydia Chancroid Epdidymitis Gonorrhea: Uncomplicated (cx, urethra, and rectum):

More information

RESISTANCE PATTERN OF URINARY TRACT INFECTION BACTERIAL ISOLATES TO SELECTED QUINOLONES

RESISTANCE PATTERN OF URINARY TRACT INFECTION BACTERIAL ISOLATES TO SELECTED QUINOLONES RESISTANCE PATTERN OF URINARY TRACT INFECTION BACTERIAL ISOLATES TO SELECTED QUINOLONES *A.R.M Momoh, *M.AC. Odike, * S. Olowo, **A.A. Momoh, **P.O. Okolo Department of *Pathological Sciences, College

More information

Chlamydial cervicitis and urethritis: single dose treatment compared with doxycycline for seven

Chlamydial cervicitis and urethritis: single dose treatment compared with doxycycline for seven Genitourin Med 1996;72:93-97 Chlamydial cervicitis and urethritis: single dose treatment compared with doxycycline for seven days in community based practises 93 E M Thorpe Jr, W E Stamm, E W Hook III,

More information

Urinary tract infection (UTI) is an exceedingly common. Article

Urinary tract infection (UTI) is an exceedingly common. Article Article Patient-Initiated Treatment of Uncomplicated Recurrent Urinary Tract Infections in Young Women Kalpana Gupta, MD, MPH; Thomas M. Hooton, MD; Pacita L. Roberts, MS; and Walter E. Stamm, MD Background:

More information